Henan Newland Pharmaceutical Co. Ltd. A (301277) - Total Liabilities

Latest as of March 2026: CN¥236.14 Million CNY ≈ $34.55 Million USD

Based on the latest financial reports, Henan Newland Pharmaceutical Co. Ltd. A (301277) has total liabilities worth CN¥236.14 Million CNY (≈ $34.55 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Henan Newland Pharmaceutical Co. Ltd. A to evaluate the company's liquid asset resilience ratio.

Henan Newland Pharmaceutical Co. Ltd. A - Total Liabilities Trend (2020–2025)

This chart illustrates how Henan Newland Pharmaceutical Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 301277 total assets.

Henan Newland Pharmaceutical Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Henan Newland Pharmaceutical Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Mediterranean Towers Ltd TA:MDTR	Israel	ILA5.15 Billion
Solaer Israel Ltd TA:SOLR	Israel	ILA1.51 Billion
Northrim BanCorp Inc NASDAQ:NRIM	USA	$3.07 Billion
Prime Medicine, Inc. Common Stock NASDAQ:PRME	USA	$209.23 Million
Idaho Strategic Resources Inc NYSE MKT:IDR	USA	$6.17 Million
Shenzhen Jiang and Associates Creative Design Co Ltd SHE:300668	China	CN¥367.47 Million
Triveni Engineering & Industries Limited NSE:TRIVENI	India	Rs15.63 Billion
Fastighetsbolaget Emilshus AB ST:EMIL-B	Sweden	Skr7.53 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down Henan Newland Pharmaceutical Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Henan Newland Pharmaceutical Co. Ltd. A's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Henan Newland Pharmaceutical Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)

The table below shows the annual total liabilities of Henan Newland Pharmaceutical Co. Ltd. A from 2020 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥228.49 Million ≈ $33.44 Million	-15.59%
2024-12-31	CN¥270.69 Million ≈ $39.61 Million	+69.16%
2023-12-31	CN¥160.02 Million ≈ $23.42 Million	-8.34%
2022-12-31	CN¥174.58 Million ≈ $25.55 Million	-33.24%
2021-12-31	CN¥261.53 Million ≈ $38.27 Million	+25.39%
2020-12-31	CN¥208.57 Million ≈ $30.52 Million	--

About Henan Newland Pharmaceutical Co. Ltd. A

SHE:301277 China Drug Manufacturers - Specialty & Generic

Market Cap

$565.70 Million

CN¥3.87 Billion CNY

Market Cap Rank

#11719 Global

#3350 in China

Share Price

CN¥9.86

Change (1 day)

+0.72%

52-Week Range

CN¥8.70 - CN¥13.63

All Time High

CN¥19.48